APA (7th ed.) Citation

K, G., E, A., M, K., D, H., L, R., CM, B., & FE, V. (2019). PD-L1 expression and clinical outcomes in patients with advanced urothelial carcinoma treated with checkpoint inhibitors: A meta-analysis. Cancer treatment reviews, 76, 51. https://doi.org/10.1016/j.ctrv.2019.05.002

Chicago Style (17th ed.) Citation

K, Ghate, Amir E, Kuksis M, Hernandez-Barajas D, Rodriguez-Romo L, Booth CM, and Vera-Badillo FE. "PD-L1 Expression and Clinical Outcomes in Patients with Advanced Urothelial Carcinoma Treated with Checkpoint Inhibitors: A Meta-analysis." Cancer Treatment Reviews 76 (2019): 51. https://doi.org/10.1016/j.ctrv.2019.05.002.

MLA (9th ed.) Citation

K, Ghate, et al. "PD-L1 Expression and Clinical Outcomes in Patients with Advanced Urothelial Carcinoma Treated with Checkpoint Inhibitors: A Meta-analysis." Cancer Treatment Reviews, vol. 76, 2019, p. 51, https://doi.org/10.1016/j.ctrv.2019.05.002.